Toggle Main Menu Toggle Search

Open Access padlockePrints

Preliminary results of a phase ii study of Brentuximab vedotin using a response adapted design in the first line treatment of patients with Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or co-morbidity (BREVITY)

Lookup NU author(s): Dr Tobias Menne


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Gibb A, Pirrie S, Linton K, Paterson K, Davies A, Collins G, Menne T, Mckay P, Fields P, Miall F, Nagy E, Wheatley K, Warbey V, Barrington S, Radford J

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 10th International Symposium on Hodgkin Lymphoma

Year of Conference: 2016

Pages: 20-20

Print publication date: 01/01/2016

Acceptance date: 02/04/2016

ISSN: 0390-6078

Publisher: Fondazione Ferrata Storti


Series Title: Haematologica